BioSpace News Archive

Drug Development

Unigene Laboratories, Inc.'s Proprietary Oral Peptide Delivery Platform is Further Validated with Cara Therapeutics’ Successful Completion of its Phase 1 Study Using Unigene’s Oral Formulation of Novel Kappa Opioid Receptor Agonist, CR845

April 3, 2012
·
7 min read
Business

Bessor Pharma, LLC. Release: AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer

April 3, 2012
·
6 min read
Meda AB Expands Presence in Asia

April 3, 2012
·
1 min read
Intertek Launches cGMP Cell Based Assays for Biologic Therapeutics in Europe

April 3, 2012
·
1 min read
Biotech Beach

Toshiba America Medical Systems Installs First Vantage Titan 3T in U.S.

April 3, 2012
·
1 min read
Drug Development

Niiki Pharma Presents Data on NKP-2235, the First Highly Orally Bioavailable Gallium-Based Anti-Cancer Agent

April 3, 2012
·
2 min read
Drug Development

Marshall Edwards, Inc. Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting

April 3, 2012
·
3 min read
Pharm Country

Watson Pharmaceuticals, Inc. Confirms LUMIGAN(R) and LATISSE(R) Patent Challenges

April 3, 2012
·
3 min read
Esperance Pharmaceuticals, Inc. Presents Poster at American Association for Cancer Research Annual Meeting Demonstrating Synergy of Lead Candidate EP-100 with Paclitaxel in In Vitro Studies

April 3, 2012
·
4 min read
Biotech Beach

Cylene Pharmaceuticals, Inc. Builds on Success, Presents Second CK2 Inhibitor at American Association for Cancer Research Meeting

April 3, 2012
·
3 min read